Tailored team approach shows promise for IBS sufferers

NCT ID NCT07534930

Ongoing Symptom relief Sponsor: Linkoeping University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a personalized treatment plan for adults with moderate-to-severe IBS. Participants receive a combination of medical care, dietary guidance, psychological therapy, and physical therapy, chosen in an order that suits them. The goal is to reduce IBS symptoms by at least 50 points on a severity scale. The study involves 150 people and lasts 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multidisciplinary treatment including medical management, dietary advice, psychological therapy, and physiotherapy
What this could lead to: If successful, this approach could offer a personalized, effective way to manage IBS symptoms and improve quality of life.
What could go wrong: This is a single-center study with 150 participants, so results may not apply to everyone. The treatment is complex and requires commitment, and not all participants may respond.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DGBI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DGBI IBS (IRRITABLE BOWEL SYNDROME)

Contacts and locations

Locations

Linköping University Hospital

Linköping, Linköping, 58185, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.